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Human colonic neuromuscular functions decline among the elderly. The aim was to
explore the involvement of senescence. A preliminary PCR study looked for age-
dependent differences in expression of CDKN1A (encoding the senescence-related p21
protein) and CDKN2A (encoding p16 and p14) in human ascending and descending
colon (without mucosa) from 39 (approximately 50: 50 male: female) adult (aged 27–
60 years) and elderly donors (70–89 years). Other genes from different aging pathways
(e.g., inflammation, oxidative stress, autophagy) and cell-types (e.g., neurons, neuron
axonal transport) were also examined. Unlike CDKN1A, CDKN2A (using primers for p16
and p14 but not when using p14-specific primers) was upregulated in both regions of
colon. Compared with the number of genes appearing to upregulate in association with
temporal age, more genes positively associated with increased CDKN2A expression
(respectively, 16 and five of 44 genes studied for ascending and descending colon).
Confirmation of increased expression of CDKN2A was sought by immunostaining for
p16 in the myenteric plexus of colon from 52 patients, using a semi-automated software
protocol. The results showed increased staining not within the glial cells (S100 stained),
but in the cytoplasm of myenteric nerve cell bodies (MAP2 stained, with identified
nucleus) of ascending, but not descending colon of the elderly, and not in the cell
nucleus of either region or age group (5,710 neurons analyzed: n = 12–14 for each
group). It was concluded that increased p16 staining within the cytoplasm of myenteric
nerve cell bodies of elderly ascending (but not descending) colon, suggests a region-
dependent, post-mitotic cellular senescence-like activity, perhaps involved with aging of
enteric neurons within the colon.
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INTRODUCTION
Growing old is associated with an increased incidence of
constipation, fecal impaction and incontinence, with reduced
quality of life. These changes have been associated with age-
related lifestyle changes, disease and use of medications which
affect gastrointestinal (GI) functions (O’Mahony et al., 2002).
The effects of aging on intestinal functions have been widely
studied in animals, especially rodents; many report reduced
intestinal motility with loss of enteric neurons, although the latter
remains controversial (e.g., Saffrey, 2004). However, compared
with humans, rodents have high metabolic rates, high rates of
aging and key differences in GI anatomy, neuronal functions,
receptor pharmacology and molecular structures, compounded
by genetic variation between different strains of laboratory
rodents capable of influencing, for example, how advancing
age affects GI functions (Wu et al., 2003; Keane et al., 2011;
Sanger et al., 2011; Richardson et al., 2016). Accordingly,
it is important to study the effects of aging on human GI
functions. In healthy aged human intestine, major functions
remain unchanged, including epithelial resistance, nerve-evoked
secretion (Krueger et al., 2016), muscle tension developed during
contraction, and numbers of myenteric neurons within different
regions of the colon (Broad et al., 2019). Nevertheless, in
many non-GI tissues, changes in several molecular pathways are
associated with aging, including those involved with development
of chronic senescence and inflammation (Bhatia-Dey et al.,
2016; Rea et al., 2018). Further, some studies in human colon
report loss of neuromuscular functions among the elderly. For
example, increasing age (20–75 years) reduced the ability of
distal colon muscle to stretch (Watters et al., 1985). In addition,
cholinergic function was found to be reduced with increasing age
in ascending colon, associated with increased immunostaining of
myenteric cell bodies for choline acetyltransferase (ChAT). Since
ChAT is synthesized within nerve cell bodies and transported
to axon terminals for acetylcholine synthesis, these findings
suggest an age-related decline in cholinergic axon transport
(Broad et al., 2019). More recently, an age-related decline
in mesenteric nerve nociception was found in human colon
(Cibert-Goton et al., 2020). Finally, expression of mRNA for
the senescence markers p16 and p21, and for elements of
the senescence-associated secretory phenotype (SASP) were
increased within mucosal biopsies from aged human colon,
especially in individuals consuming normal western diets (argued
to increase cellular senescence) and not under calorie restriction
(Fontana et al., 2018).
p14, p16, and p21 are markers for cellular senescence. The
p21 protein, encoded by the CDKN1A gene, is associated with
acute senescence in many tissues in organisms of all age (Stein
et al., 1999), including upregulation in myenteric neurons of
the mouse intestine following short-term caloric restriction (Jurk
et al., 2012). This involves exit of the cell from the cell cycle and
secretion of inflammatory mediators, with affected cells usually
rapidly cleared by the immune system. The expression of p21
may be facilitated by p14, encoded by the CDKN2A gene (Sherr,
2006; Bieging et al., 2014). However, with increasing age, cells
can enter chronic senescence, involving chromatin remodeling
and transcription changes (van Deursen, 2014), thought to be
potentially causative for different aspects of aging (Bhatia-Dey
et al., 2016). The p16 protein, also encoded by the CDKN2A gene,
is a marker for chronic cellular senescence (Stein et al., 1999). p16
is a cell cycle regulator usually expressed in the nucleus, where it
interacts with CDK4 to prevent the G1/S transition (Serrano et al.,
1993; Ciesielska et al., 2017).
Aging of the human bowel is poorly understood, but a
decline in enteric cholinergic function (Broad et al., 2019) and
perhaps other functions, raises questions about the existence and
roles of age-related degenerative pathways in the aging bowel.
A senescent-like state has previously been noted in mature post-
mitotic enteric neurons in the intestine of elderly mice (Jurk et al.,
2012) but similar studies have not yet been conducted for the
human enteric nervous system. Additionally, regional differences
in the age-related decline of enteric cholinergic function (Broad
et al., 2019) highlighted the importance of considering ascending
and descending colon as separate regions. The current study
began as a pilot investigation which used qPCR to explore the
possibility that senescence might be upregulated in the mucosa-
free wall of human ascending and descending/sigmoid colon
(containing multiple cell-types including muscle and enteric
neurons) of the “elderly” (≥70 years), compared with younger
“adults” (25–60 years). Analysis of the data generated, highlighted
a potential age-related increase in expression of the gene for
p16, particularly in the ascending colon. The involvement of p16
with senescence, often considered as the exit of a proliferating
cell from the cell cycle (Serrano et al., 1993; Ciesielska et al.,
2017), created the hypothesis that potentially proliferative cells
within the myenteric plexus had become senescent in the aged
human colon. We focused on the enteric neurons (because a
senescent-like state may exist in enteric neurons of the aged
mouse; Jurk et al., 2012) and glial cells (because of their loss
within the myenteric plexus of aged rats and potential to undergo
neurogenesis in mice following damage to enteric ganglia;
Phillips et al., 2004; Laranjeira et al., 2011). Immunofluorescence
was used to confirm the change and localize the upregulation of
the p16 protein. The results identified p16 within the cytoplasm
of myenteric nerve cell bodies, not the nucleus, and not in
glial cells, implying a role for post-mitotic cellular senescent-like
mechanisms in declining enteric neuron functions during aging.
MATERIALS AND METHODS
Human Tissues
Macroscopically-normal ascending and descending/sigmoid
(referred to hereon as descending) colon was taken 5–10 cm
from the tumor following surgery for non-obstructing bowel
cancer, as described previously (Broad et al., 2019). No patient
had previous chemoradiotherapy or diagnosis of inflammatory
bowel disease. Tissues were immersed into Krebs solution
(mmol L−1: NaCl 121.5, CaCl2 2.5, KH2PO4 1.2, KCl 4.7, MgSO4
1.2, NaHCO3 25, glucose 5.6 at room temperature, equilibrated
with 5% CO2 and 95% O2) and transferred to the laboratory
within 2 h of surgery. Here they were dissected for separate
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muscle and mucosa storage in RNAlater (Sigma Aldrich) and/or
prepared for fixing into full thickness paraffin blocks.
RNA Extraction
Extraction was from colon (mucosa removed) previously stored
at −80◦C in RNAlater. This was homogenized in TRIzol and
RNA extraction carried out using the Direct-zol RNA Miniprep
Kit (Zymo Research) according to manufacturer’s instructions.
qPCR
cDNA synthesis was performed using the SuperScript VILO
cDNA Synthesis Kit (Invitrogen). SYBR Green reagents (Thermo
Fisher) were used for qPCR analysis, and primers were used
at 40 µM concentration (Supplementary Table 4). mRNA
concentrations were normalized against two commonly used
“housekeeping” genes: GAPDH and ATP5B (determined by
geNorm kit, PrimerDesign).
Tissue samples were grouped according to age and region
of colon. Age groups were defined as “adults” (25–60 years)
and “elderly” (≥70 years) and ascending colon and descending
colon were examined separately; adult ascending n = 9, elderly
ascending n = 10, adult descending n = 10, elderly descending
n = 10. These groups were taken from previously published
research which defined an age- and region-dependent decline
in neuromuscular function of human colon (Broad et al., 2019).
The adult samples had an age range of 27–60 years (median 53)
and were 53% male. The elderly samples had an age range of
70–89 years (median 79) and were 50% male.
CD45 Analysis
Using formalin-fixed, paraffin-embedded 4 µm sections,
immunohistochemistry against CD45 (Roche, 760–4279) was
carried out using the Ventana system. Slides were counterstained
using haematoxylin and digitally scanned. Samples were analyzed
(n = 10 for each of four groups; adult and elderly ascending
colon, adult and elderly descending colon; a separate cohort
to that used for qPCR and p16 immunofluorescence). Adult
samples were 30–60 years of age (median 56) and 50% male.
Elderly samples were 70–91 years of age (median 77.5) and
50% male. Each sample consisted of two, non-consecutive wax
sections, of 4 µm thickness.
Images were taken at 20x magnification using automated
setting for focus and using set exposures across all samples.
These were analyzed by two independent observers blind to
age and colon region. Up to 24 regions of interest (ROIs),
365 µm × 365 µm, were placed on each section using NDP
View 2 and FIJI software’s. To meet inclusion criteria, at least four
ROIs were analyzed in each region of muscle: 4–8 in longitudinal
muscle, 4–8 in circular muscle adjacent to longitudinal muscle,
4–8 in circular muscle adjacent to mucosa. Therefore, for each
patient up to 48 ROIs were analyzed, with an area of 6.3 mm2.
Images were judged by whether enough ROIs could be taken to
meet inclusion criteria. Final sample sizes for adult and elderly
ascending colon, adult and elderly descending colon were n = 7,
9, 10 and 9, respectively, for observer 1, n = 6, 6, 9 and 8 for
observer 2. Together, a total of 340 mm2 was analyzed (range
3.2–6.3 mm2/sample; median 5.9 mm2).
For each ROI, CD45-positive cells were counted, and FIJI
software used to estimate total cell count from the haematoxylin-
stained nuclei.
p16 Analysis
4 µm sections were dewaxed in xylene, rehydrated in ethanol
and distilled water, unmasked using citrate buffer (pH 6), and
blocked in 1% BSA. Primary antibodies were against p16INK4A
(1:200, ProteinTech, 10883-1-AP, AB_2078303), S100 (1:3,000;
Abcam, ab14849, AB_301508) and MAP2 (1:500; Abcam,
ab5392, AB_2138153). Secondary antibodies [Abcam, ab150073
(AB_2636877), ab150105 (AB_2732856), ab175477] were applied
at a concentration of 1:500, with DAPI and HCS CellMaskTM
(1 µg/ml and 1:200,000 respectively, both Thermo Scientific).
A p16INK4A fusion protein (ProteinTech; Ag1328) was used
as blocking peptide for the p16 antibody. A volume was used
equivalent to 5x the amount of antibody by weight. During
control experiments antibody solutions were incubated with or
without blocking peptide for 1 h at room temperature prior to
application (Supplementary Figure 2).
Myenteric plexus was imaged using IN Cell Analyser 2200
and analyzed using IN Cell Developer Toolbox software (both
GE Healthcare). Images were taken at 20x magnification using
automated setting for focus and exposure. DAPI and MAP2
staining of myenteric neurons were clearly defined and showed
distinct nuclei/cells. To define regions of positive staining,
thresholds were systematically set relative to the smooth muscle
(negative internal control for staining within each section)
(Figures 6A–C′). This process was performed whilst blinded
to the donor age and region of colon. This enabled a robust,
automated protocol for quantification of positively stained
regions. Visual inspection was routinely performed to confirm
the validity of the automated protocol.
Only MAP2-positive cells associated with a nucleus were
analyzed. p16 fluorescence was measured in the nucleus and
cytoplasm (region of MAP2 staining minus the nucleus, as shown
by DAPI) using two methods. The first involved automated
quantification of the average fluorescence intensity within the
ROI, from which background fluorescence of smooth muscle
(the internal control) was subtracted. This detected changes in
cell-wide, dispersed fluorescence, but may not have detected
more localized changes in fluorescence, such as foci. The second
method involved automated quantification of the proportion
of the ROI positive for p16 fluorescence. In this instance, the
threshold for measurement was systematically defined as twice
the level of background fluorescence in smooth muscle. This
detected changes in fluorescent foci, although it may not have
detected dispersed changes in fluorescence in the ROI. To
determine the proportion of MAP2-stained cells in which there
was a high level of confidence for p16 staining we counted the
number of cells in which 50% or more of the cytoplasmic area
was above threshold for p16 staining.
In total, samples from 58 patients were analyzed, with 14–
16/group (adult and elderly, ascending and descending colon).
Samples which did not contain myenteric plexus or did not
have clearly defined MAP2-positive cells were removed from
analysis. Final analysis was carried out using samples from 52
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individuals (adult ascending n = 14, elderly ascending n = 12,
adult descending n = 13, elderly descending n = 13). Adult
samples were 27–60 years of age (median 56) and 52% male.
Elderly samples were 70–91 years of age (median 79) and
52% male. Four individuals were additionally used for negative
controls without p16 antibody. Final analysis included 5,710
neurons, with a median of 71 (range 13–293) neurons/patient.
Statistics and Data Analysis
Data from qPCR were analyzed using ExpressionSuite (Thermo
Fisher Scientific, Walton, MA, United States) software using
the 11Ct method and expressed as fold-changes comparative
to the control group. The qPCR data and those from the
immunohistochemistry/immunofluorescence experiments were
analyzed using student’s t-tests to compare between age groups
for each region of colon. Proprietary software (GraphPad Prism
v8.0, San Diego, CA, United States) was used for all statistical
tests. A P-value of ≤0.05 indicated statistical significance.
RESULTS
Changes in Gene Expression Determined
by qPCR
Analysis was performed on RNA extracted from full thickness
colon, with mucosa removed, containing a mixture of cell types,
including but not limited to neurons, glial cells, interstitial cells of
Cajal and smooth muscle. Genes were chosen from the literature
to represent senescence and other pathways reported to be altered
with advancing age (oxidative stress, inflammation, angiogenesis,
autophagy; Lahteenvuo and Rosenzweig, 2012; He et al., 2013;
Bhatia-Dey et al., 2016; Franceschi et al., 2017; Liguori et al.,
2018), pathways involved in neuron axonal transport (suggested
to decline in enteric cholinergic neurons of ascending colon of the
elderly; Broad et al., 2019) and genes to mark specific cell types,
such as interstitial cells of Cajal (ICCs), neurons and neuronal
subtypes. Supplementary Table 1 provides the full list of genes
studied, with brief descriptions.
Within the ascending colon, significant age-related increases
in expression occurred for five of the 44 genes studied, including
CDKN2A and TNF. For CDKN2A, the p16 product was not
examined separately (the primers were for p16INK4A and p14ARF).
The p14 product tended to increase but this was not statistically
significant (Figure 1A and Supplementary Table 2). In the
descending colon only two of the 44 genes were significantly
upregulated in the elderly (Figure 1B and Supplementary
Table 2), including CDKN2A (but not the p14 product of this
gene), the only gene upregulated in an age-dependent manner in
both regions (Figure 2). In both regions of colon, the increases
were small but statistically significant, e.g., TNF increased 2.3-
fold and CDKN2A increased 1.6-fold in ascending colon of the
elderly compared to adult ascending colon (P < 0.05). A sub-
analysis of gene expression for CDKN2A, DUOX2, CDKN1A,
TNFα, IL13 and IL6 (exemplars showing relatively high variation
in expression) failed to show significant sex-related differences
in levels of expression (one way ANOVA with Tukey’s multiple
comparisons test; data not shown).
Changes in Gene Expression Relative to
Levels of p16 Gene Expression
Cellular senescence is a proposed marker of biological rather than
chronological age (Bhatia-Dey et al., 2016). Since the increased
CDKN2A expression (using primers amplifying both p16INK4A
and p14ARF) appeared to be due mostly to increased p16
expression, a marker of chronic senescence (Stein et al., 1999), the
results from the qPCR study were grouped into tissues expressing
high or low levels of CDKN2A about the median value for the
region, divided into “high” or “low” CDKN2A expression groups.
The age of the patient was not considered. Expression levels of
the other tested genes were then compared between these groups
(Figure 3 and Supplementary Table 3).
More genes showed statistically significant, positive
association with the higher levels of CDKN2A expression than
with age. This occurred with more genes in ascending (16 genes)
compared to descending colon (five genes) (Figures 3A,B).
CDKN2A-associated upregulations were found in ascending
colon for one of seven inflammation genes, 0/1 senescence genes,
5/13 oxidative stress genes, 5/6 autophagy genes, 2/6 axonal
transport genes and 4/10 apoptosis genes (some genes included
in multiple categories). No genes were downregulated with high
CDNK2A expression in either region.
CD45 Protein
There was no evidence of microscopic inflammation in any
section of colon, based on routine tinctorial staining (H&E).
Examination of CD45-positive cells showed no age-related
changes in numbers of CD45-positive cells in any region of the
muscle in ascending or descending colon from the adult or elderly
patient groups (Figure 4 and Supplementary Figure 4). CD45
protein is expressed on many cells of the hematopoietic system,
including B cells and T cells (Rheinlander et al., 2018).
p16 Protein
Given the potentially causative role for senescence in
the pathways of aging (see section “Introduction”),
immunofluorescence was used to investigate the location of
p16 staining within the colon and determine if staining levels
change with age.
Immunofluorescence was carried out in sections of full
thickness (mucosa removed) ascending and descending colon
from the adult and elderly groups using p16, DAPI, and either
MAP2 as a neuronal marker, or S100, as a glial cell marker.
Very thin 4 µm sections were used to facilitate the localization
of staining during imaging and automated quantification. The
p16 antibody co-stained with MAP2 (respectively in 8.6% (65
of 755 cells), 26.0% (231/890 cells), 13.3% (272/2,041 cells) and
11.6% (170/1,468 cells) of cells in adult and elderly ascending
colon and in adult and elderly descending colon, and 0.0%
(0/557 cells) for negative controls, as defined by cells which
show staining over 50% of the area of cytoplasm) with little or
no co-staining with S100 or DAPI in any of the cells studied,
and little or no staining in the smooth muscle (Figure 5).
The p16 antibody consistently showed strong and defined co-
staining with the MAP2 antibody, often clearly demonstrating
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FIGURE 1 | Gene expression in (A) elderly ascending colon and (B) elderly descending colon, shown relative to gene expression in adult ascending or descending
colon, which has been normalized to 1 for each gene (shown by dashed line). ATP5B and GAPDH were used as endogenous controls. Results represent
fold-change differences. #p < 0.1 and *p < 0.05. Student’s t-test used to calculate P value for each gene, comparing between age groups.
FIGURE 2 | CDKN2A gene expression (using primers for p16INK4A and p14ARF) is significantly increased in elderly ascending and descending colon. Panel (A)
compares the elderly and adult samples from both regions, relative to expression in adult ascending colon, which has been normalized to 1. ATP5B and GAPDH
were used as endogenous controls. Results represent fold-change differences. Adult samples (25–60 years old) are represented by •. Elderly samples (70 + years
old) are represented by . Bars indicate data mean. *P < 0.05. Student’s t-test used to calculate P value for each gene, comparing between age groups. Panel (B)
shows the correlations between CDKN2A gene expression and increasing age (years). P values for linear regression lines are, respectively, 0.0087 and 0.0063 for
ascending and descending colon (calculated using Prism).
the shape of the cell (Figures 5, 6). Controls for the p16 antibody
determined reliability; sections of endocervical adenocarcinoma
served as a positive control, where staining occurred in both
cytoplasm and nucleus (Supplementary Figure 1). Additionally,
p16 blocking peptide blocked binding of p16, but not MAP2
antibody. These controls also served to exclude the possibility
of lipofuscin autofluorescence as the source of the signal
(Supplementary Figure 2).
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FIGURE 3 | Gene expression in (A) ascending colon and (B) descending colon with high CDKN2A (p16INK4A and p14ARF) expression, shown relative to gene
expression in ascending or descending colon with low p16 expression, which has been normalized to 1 for each gene (shown by dashed line). ATP5B and GAPDH
were used as endogenous controls. Results represent fold-change differences. #P < 0.1; *P < 0.05; **P < 0.01; and ***P < 0.001. Student’s t-test used to calculate
P value for each gene, comparing between age groups.
Cytoplasmic and nuclear p16 staining within the cell bodies
of MAP2-positive neurons were analyzed as a percentage of area
covered (see section “Materials and Methods”; Figures 6A–C′),
and by the average level of fluorescence (see section “Materials
and Methods”) in the region of interest. In total, 5,710 neurons
from 52 patients were analyzed between the four groups. No age-
related changes in p16 protein staining were found in descending
colon (Figures 6D–G). In ascending colon, p16 protein staining
was increased within the neuronal cell body cytoplasm of the
elderly compared to adults. This was detected by measuring the
area of p16 coverage and the level of fluorescence in the neuronal
cytoplasm (Figures 6D,F). There was no age-related change in
area of p16 staining within neuronal nuclei, and although an
increase in the level of p16 fluorescence occurred in the elderly
compared to the adults (Figures 6E,G), the staining was largely
peripheral and not possible to exclude from overlap with the
cytoplasmic staining (Supplementary Figure 3).
DISCUSSION
This study demonstrated increased p16 expression within
myenteric neurons of the aged human colon. An initial search
for age-related changes in gene expression in the intact colon
(mucosa removed but containing multiple cell-types including
muscle and enteric neurons) highlighted the possibility of small
increases in CDKN2A (when using primers for p16INK4A and
p14ARF together but not for p14ARF alone) and certain other
genes. Notably the latter were more associated with increased
expression of CDKN2A rather than temporal age. On this basis,
p16 immunostaining was performed, to examine the potential for
increases in p16INK4A expression and if confirmed, determine the
location and level of protein expression.
A hallmark of senescence is the exit of a proliferating cell from
the cell cycle. This involves interaction of p16 with CDK4, so
p16 is typically considered a nuclear protein (Serrano et al., 1993;
Ciesielska et al., 2017). Thus, the second part of the study began
with the hypothesis that upregulated CDKN2A would be reflected
by p16 staining in the nuclei of cells undergoing proliferation
within the aged human colon, The focus was on enteric neurons
and glial cells (see section “Introduction”). However, S100-
positive glial cells exhibited little-or-no p16 staining. Rather, high
levels of staining were found in nerve cell bodies of the myenteric
plexus, but within the cytoplasm and not clearly within the
nucleus. Antibody fluorescence was measured as a representative
of protein expression. Although inter-individual variability
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FIGURE 4 | No significant age-related differences were seen in the percentage of CD45-positive cells in colon sections in ascending or descending colon. Panels
(A–C) show methods used to calculate the percentage of CD45-positive cells. A bin for analysis was taken (A), and thresholding was used to identify CD45-positive
cells and nuclei, which were then counted. Statistical tests compared results for each colon region between age groups; adult (25–60 years old; •) and elderly
(70 + years old; N). Bars indicate data mean. Data was collected separately for: longitudinal muscle, circular muscle near the myenteric plexus, and circular muscle
near the mucosa. Data shown represents an average from the three regions from each individual. No statistical significance was found when comparing age groups
for the three regions individually, or when grouped. Data was analyzed by two independent observers. Results from one observer are shown in panel (D) as an
example.
was high, the data showed that cytoplasmic fluorescence was
increased in the neurons of ascending but not descending colon
of the elderly, suggesting region-dependent upregulation of p16
during aging within enteric neurons.
Understanding the mechanisms of declining neuromuscular
functions could identify ways of promoting healthy aging of
the bowel. However, experiments are hampered by lack of
routinely available primary cultures of multiple human cell-
types. Accordingly, this study investigated the intact colon
(mucosa removed) and began by using qPCR to look for age-
related expression of genes in degenerative pathways, including
cellular senescence, mitochondrial dysfunction and low-grade
inflammation (Lopez-Otin et al., 2013; Bhatia-Dey et al., 2016;
Franceschi et al., 2017). This approach has several weaknesses,
including the limited number of genes examined, together with
any unintended selection bias. Further, the use of intact colon
means that relatively small amounts of extracted mRNA are likely
to be derived from neurons and other cells embedded within the
much larger muscle mass. Thus, if genes of interest are in neurons
at low copy number, statistically significant increases are difficult
to detect, compared with genes which have a high intensity of
expression in neurons (e.g., the present study detected TUBB3).
An additional weakness was the use of primers for CDKN2A
encoding p16INK4A and p14ARF, although this was mitigated
to some extent by additional experiments with primers specific
for p14ARF alone. Nevertheless, although only an exploratory
study, the results suggested an increase in expression of CDKN2A
(encoding p16INK4A and p14ARF, not p14ARF alone) and several
other genes within the ascending colon of the elderly, with
increased expression of a smaller number in descending colon.
CDKN2A (p16INK4A and p14ARF, not p14ARF alone) was the
only gene tested in which expression was upregulated in both
ascending and descending colon from the elderly (although fold
change was greater in ascending colon). By contrast, CDKN1A
(encoding the senescence protein p21), showed no changes with
age in either region of colon. Although not an exclusive divide
(Krishnamurthy et al., 2004), the latter is often thought to be
involved mostly with “acute” senescence at all ages, whereas
p16 is important for “chronic” senescence, being associated with
aging and a failure of the immune system to clear senescent
cells (Stein et al., 1999). Indeed, chronic senescence may be a
better marker of how tissue ages in response to genetic and
environmental influences over time (Bhatia-Dey et al., 2016).
For this reason, the gene expression data from the present
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FIGURE 5 | Co-localization of p16 with a neuronal marker in the myenteric plexus, but with little or no co-localization with a glial cell marker. Immunofluorescence for
a neuronal marker, MAP2 (A,B), shows co-staining with p16 (A′,A′′,B′,B′′). However, immunofluorescence for a glial cell marker, S100 (C,D), shows minimal
co-localization with p16 (C′,C′′,D′,D′′). It is noteworthy that p16 staining is present mainly in the neuronal cytoplasm and not the nucleus. Most nuclear staining
observed was peripheral, and it was impossible to rule out overlap with the cytoplasm. Neuronal nuclei are present but do not take up DAPI stain as well as other cell
types. S100 staining was not further quantified. Scale bar represents 25 µm.
study were reanalyzed according to the degree of expression
of CDKN2A. The results showed that high levels of CDKN2A
were associated with increased expression of a greater number
of genes, compared with the number associated with advanced
age, especially in ascending colon. Interestingly, the qPCR data
showed some association between CDKN2A and components
of the SASP, including TNF, VEGFB and genes involved with
oxidative stress (expression of IL-6, often associated with SASP,
was unchanged). Notably, the SASP may be context-dependent
with different profiles, depending on cell type and cause of
senescence (Gorgoulis et al., 2019).
To explore a possible association between chronic senescence
and the aged colon, an immunofluorescence study was
undertaken with p16. As a control to examine the integrity of the
tissue, an immunohistochemistry study with CD45 demonstrated
an absence of confounding increases in hematopoietic cells
in each of the age groups and regions of colon investigated.
Although a greater number of samples is now needed to make
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FIGURE 6 | Increased p16 protein expression with advanced age in neuronal cytoplasm in ascending but not descending colon. Thresholding was used to identify
positive immunostaining. Panels (A–C) show the original immunostaining, and panels (A′,B′,C′) show the respective thresholding, with areas of positive staining
shown in color. Images DAPI (A,A′) and MAP2 (B,B′) determined positive and negative areas of staining. For p16 (C,C′) the level of fluorescence in the surrounding
smooth muscle was measured, and the threshold was set at twice this background level. Scale bar in A is 25 µm. The results were calculated using two methods.
The first, is a calculation of the percentage of area covered by p16-positive staining in the region of interest [shown in panels (D,E)] as determined by thresholding.
The second method is a measurement of the average level of p16 fluorescence in the region of interest relative to background (F,G). Results are for the cytoplasm
(D,F) and the nucleus (E,G). Bars indicate data mean. N = 52: adult ascending colon n = 14, elderly ascending n = 12, adult descending n = 13, elderly descending
n = 13. *p < 0.05 and **p < 0.01. Student’s t test used to compare between age groups. Panel (D) shows a significant increase in p16 coverage in the neuronal
cytoplasm of the ascending colon when comparing samples from adult (25–60 years old; •) and the elderly (70+ years old; N). Panel (E) shows no age-related
changes in p16 coverage in neuronal nuclei for either colon region. Panels (F,G) show age-related increases in p16 fluorescence in the ascending colon in cytoplasm
(F) and nuclei (G) of myenteric plexus neurons; changes in the nuclei may be due to overlap with the cytoplasm.
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definitive conclusions, the subsequent p16 immunofluorescence
study (n = 12–14 each age group and region of colon; N = 52
total) showed increased staining in myenteric nerve cell bodies
of ascending colon from the elderly. Interestingly, this was not
replicated in descending colon, indicating that the age-related
increase in CDKN2A expression in this region of colon did not
translate to increased p16 protein staining; the reasons for this
lack of translation are not clear but could be related to the
relatively small increase in CDKN2A in descending colon.
To investigate the biology of human GI neuromuscular and
other functions it is important to use human GI tissues, often
removed at surgery for disease. This means that to make progress
such studies must confront any influence of the disease on
the data generated, in addition to variations in patient age,
gender and genetic background (Sanger et al., 2013). As in
the present study, the use of an optimal sample size and an
understanding of the clinical history of the tissue donors are
part of the methods used to minimize variability. Thus, if
properly controlled, a strength of the use of human tissues is
that this can highlight differences between animal and human
GI functions, especially important when conclusions are based
on particular strains of rodents with unproved translational
significance (Sanger et al., 2013). An investigation into the role
of p16 in the aging human bowel presents its own challenges
because although all tissues, irrespective of colon region and
age, were taken as “macroscopically normal” sections 5–10 cm
away from the tumor in cancer patients (see section “Human
Tissues”), the possibility remains that the cancer itself could have
influenced the expression of p16 and not aging. Thus, p16 may
occur in the cytoplasm of carcinoma cells (colorectal, head and
neck squamous cell, melanoma, astrocytomas; Straume et al.,
2000; Zhao et al., 2003, 2012; Arifin et al., 2006), perhaps to inhibit
nuclear function (Nilsson and Landberg, 2006). Nevertheless,
the present data are striking because although all tissues were
removed from cancer patients the region- and age-dependent
increase in p16 staining argues in favor of an association with
aging. Such a conclusion finds consistency with a previous
report of an age-related decline in cholinergic function in the
same ascending colon region, not in the descending colon
(Broad et al., 2019).
It has conventionally been thought that senescence occurs
in mitotic cells, involving upregulation of cell cycle-related
genes (including p16), accompanied by exit from the cell cycle
(Carnero, 2013). Nevertheless, Post-Mitotic Cell Senescence
(PoMiCS) has been described, in which post-mitotic cells
activate p16 and/or the p53/p21 axis, accumulate lipofuscin
(“age pigment”; another indicator of senescence; Moreno-García
et al., 2018) and secrete components of the SASP (Jurk et al.,
2012; Sapieha and Mallette, 2018). This has been found in
intestinal myenteric neurons of mice, increasing in frequency
during advancing age (Jurk et al., 2012). PoMiCS cells exhibited
severe DNA damage and oxidative stress, expressed markers
of senescence, including p16, and demonstrated morphological
changes typical of senescent cells, e.g., accumulation of lipofuscin,
increased size of mitochondria, and reduced heterochromatin
(Tan et al., 2014; Wan et al., 2014; Ishikawa and Ishikawa, 2019).
Ishikawa and Ishikawa (2019) showed immunofluorescence
images demonstrating cytoplasmic p16 protein staining in
long-term cultured post-mitotic rat neurons. The present study
now suggests that PoMiCS could occur within human myenteric
neurons of the elderly.
Staining of the neuronal cytoplasm by the p16 antibody,
with little-or-no nuclear staining, was not anticipated since p16
acts as a negative regulator of cell cycle progression at the G1
checkpoint in the nucleus (Serrano et al., 1993). Nevertheless, p16
has been reported to have roles in non-cell cycle-related processes
including anoikis, matrix-dependent cell migration, protection
from DNA damage and neuroprotection in aging mice (Fahraeus
and Lane, 1999; Plath et al., 2000; Sen et al., 2017; Micheli et al.,
2019), and in addition, has been shown to bind to cytoplasmic
proteins (e.g., cytoplasmic β-actin and γ-actin, and Rin2; Souza-
Rodrigues et al., 2007). Further, two forms of p16 are proposed,
one in both the nucleus and cytoplasm, the other specific to the
cytoplasm: Nilsson and Landberg, 2006). This evidence could
suggest cytoplasmic roles for p16 unrelated to the cell cycle.
It is not clear if cytoplasmic p16 protein expression in
myenteric neurons is involved with senescence or any of the
above-described activities of p16, exerting a pathological or
beneficial activity in the aging colon. Confirmatory studies are
now needed to determine the presence or absence of other
senescence and SASP protein markers in the neurons, and
whether such changes are regulated by cytoplasmic p16.
Conclusion
The present study in human colon supports the wealth of
literature which implicates p16 as a key component in aging.
In particular, the correlations between age, colon region, and
cytoplasmic p16 staining in the myenteric neurons suggests
a role for p16 in post-mitotic human enteric neurons during
aging. Further experiments are needed to explore this possibility,
perhaps by western blotting with human isolated primary
cultures of human enteric neurons, and by double-labeling
of neurons to identify the nerve phenotype expressing p16.
In particular, other markers of senescence (e.g., senescence-
associated beta-galactosidase) must be examined to determine
if the increase in p16 expression reflects senescence or some
other age-related role of p16. Regardless, the data is consistent
with the suggestion that ascending colon is an important area
in age-related decline of human colon functions, leading to
reduced enteric nerve reserve capacity and increased likelihood
of developing bowel disorders (Broad et al., 2019). The reason
for region-dependence is not understood. Changes in intestinal
microbiota during advanced age are reported (Vaiserman et al.,
2017) including differences in metabolic and fermentation
profiles in different colonic regions (Firrman et al., 2020).
For example, concentrations of short chain fatty acids and
fermentable substrates are higher in ascending colon, being
associated with inflammatory changes (Macfarlane et al., 1992;
Karlund et al., 2019). Perhaps these and other substances
damage myenteric neurons within the ascending colon, aided
by longer storage of food residue in this region compared to
descending/sigmoid colon (Proano et al., 1990) and increased
mucosal permeability during advancing age (Nicoletti, 2015, but
see one large-scale study in vitro which found no change in
mucosal permeability; Krueger et al., 2016).
Frontiers in Neuroscience | www.frontiersin.org 10 October 2021 | Volume 15 | Article 747067
fnins-15-747067 October 6, 2021 Time: 14:55 # 11
Palmer et al. Senescence in Human Colon
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article/Supplementary Material, further inquiries can be
directed to the corresponding author.
ETHICS STATEMENT
The studies involving human participants were reviewed
and the study was approved by the East London Research
Ethics Committee (REC: 10/HO703/71) and subsequently
by the London City Road and Hampstead Research Ethics
Committee (REC: 15/LO/21/27). All patients were fully informed
of the aims of the study and use of tissue, but were
not involved in study design, interpretation of results, or
writing/editing of this report. Written informed consent
was obtained from all patients undergoing surgery, for use
of macroscopically-normal ascending and descending/sigmoid
colon. The patients/participants provided their written informed
consent to participate in this study.
AUTHOR CONTRIBUTIONS
AP performed the qPCR, the immunohistochemistry
and subsequent analysis. SEp, EC, and YX performed
immunohistochemistry and subsequent analysis. LG
performed immunohistochemistry analysis. AP supervised the
immunohistochemistry studies, with interpretation guided by
JM. CB provided the p16 antibody and its validation. SEp, AP,
EC, SEl, JC-A, and CK were instrumental in obtaining human
tissue. ME guided interpretation of qPCR analysis. AP and GS
designed the study and wrote the manuscript. GS obtained the
funding. All authors had access to the study data, critiqued, read
and approved the manuscript.
FUNDING
AP was supported by research grants from Takeda
Pharmaceuticals and by the Bowel and Cancer research charity.
SEl was supported by Takeda Pharmaceuticals. YX received
funding from the China Scholarship Council.
ACKNOWLEDGMENTS
We would like to thank the colorectal surgeons and pathologists
of Barts and the London NHS Trust for providing us with
tissue for laboratory use. We would also like to thank the other
consultant colorectal surgeons and pathologists at Barts Health
for assisting with identification of patients for recruitment into
this study and for providing tissue suitable for laboratory use.
SUPPLEMENTARY MATERIAL




Arifin, M. T., Hama, S., Kajiwara, Y., Sugiyama, K., Saito, T., Matsuura, S., et al.
(2006). Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis
in high-grade astrocytomas. J. Neurooncol. 77, 273–277. doi: 10.1007/s11060-
005-9037-9035
Bhatia-Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E. O., and Csoka, A. B.
(2016). Cellular senescence as the causal nexus of aging. Front. Genet. 7:13.
doi: 10.3389/fgene.2016.00013
Bieging, K. T., Mello, S. S., and Attardi, L. D. (2014). Unravelling mechanisms of
p53-mediated tumour suppression. Nat. Rev. Cancer 14, 359–370. doi: 10.1038/
nrc3711
Broad, J., Kung, V. W. S., Palmer, A., Elahi, S., Karami, A., Darreh-Shori, T., et al.
(2019). Changes in neuromuscular structure and functions of human colon
during ageing are region-dependent. Gut 68, 1210–1223. doi: 10.1136/gutjnl-
2018-316279
Carnero, A. (2013). Markers of cellular senescence. Methods Mol. Biol. 965, 63–81.
doi: 10.1007/978-1-62703-239-1_4
Cibert-Goton, V., Kung, V. W. S., McGuire, C., Hockley, J. R. F., Tranter,
M. M., Dogra, H., et al. (2020). Functional and anatomical deficits in visceral
nociception with age: mechanism of silent appendicitis in the elderly? Pain 61,
773–786. doi: 10.1097/j.pain.0000000000001764
Ciesielska, U., Zatonski, T., Nowinska, K., Ratajczak-Wielgomas, K., Grzegrzolka,
J., Piotrowska, A., et al. (2017). Expression of cell cycle-related protein p16, p27
and Ki-67 proliferating marker in laryngeal squamous cell carcinomas and in
laryngeal papillomas. Anticancer. Res. 37, 2407–2415. doi: 10.21873/anticanres.
11580
Fahraeus, R., and Lane, D. P. (1999). The p16(INK4a) tumour suppressor
protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by
blocking PKC-dependent localization of alphavbeta3 to focal contacts. EMBO J.
18, 2106–2118. doi: 10.1093/emboj/18.8.2106
Firrman, J., Liu, L., Tanes, C., Friedman, E. S., Bittinger, K., Daniel, S., et al. (2020).
Metabolic analysis of regionally distinct gut microbial communities using an
in vitro platform. J. Agric. Food Chem. 68, 13056–13067. doi: 10.1021/acs.jafc.
9b05202
Fontana, L., Mitchell, S. E., Wang, B., Tosti, V., Van Vliet, T., Veronese, N., et al.
(2018). the effects of graded caloric restriction: xii. comparison of mouse to
human impact on cellular senescence in the colon. Aging Cell 17:e12746. doi:
10.1111/acel.12746
Franceschi, C., Garagnani, P., Vitale, G., Capri, M., and Salvioli, S. (2017).
Inflammaging and ’garb-aging’. Trends Endocrinol. Metab. 28, 199–212. doi:
10.1016/j.tem.2016.09.005
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop,
C., et al. (2019). Cellular senescence: defining a path forward. Cell 179,
813–827.
He, L. Q., Lu, J. H., and Yue, Z. Y. (2013). Autophagy in ageing and ageing-
associated diseases. Acta Pharmacol. Sin. 34, 605–611. doi: 10.1038/aps.2012.
188
Ishikawa, S., and Ishikawa, F. (2019). Proteostasis failure and cellular senescence in
long-term cultured postmitotic rat neurons. Aging Cell 19:e13071. doi: 10.1111/
acel.13071
Jurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., et al. (2012).
Postmitotic neurons develop a p21-dependent senescence-like phenotype
driven by a DNA damage response. Aging Cell 11, 996–1004. doi: 10.1111/j.
1474-9726.2012.00870.x
Karlund, A., Gomez-Gallego, C., Turpeinen, A. M., Palo-Oja, O. M., El-Nezami,
H., and Kolehmainen, M. (2019). Protein supplements and their relation with
nutrition, microbiota composition and health: is more protein always better for
sportspeople? Nutrients 11:829. doi: 10.3390/nu11040829
Keane, T. M., Goodstadt, L., Danecek, P., White, M. A., Wong, K., Yalcin, B.,
et al. (2011). Mouse genomic variation and its effect on phenotypes and gene
regulation. Nature 477, 289–294. doi: 10.1038/nature10413
Frontiers in Neuroscience | www.frontiersin.org 11 October 2021 | Volume 15 | Article 747067
fnins-15-747067 October 6, 2021 Time: 14:55 # 12
Palmer et al. Senescence in Human Colon
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L.,
et al. (2004). Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest. 114,
1299–1307. doi: 10.1172/JCI22475
Krueger, D., Michel, K., Zeller, F., Demir, I. E., Ceyhan, G. O., Slotta-Huspenina,
J., et al. (2016). Neural influences on human intestinal epithelium in vitro.
J. Physiol. 594, 357–372. doi: 10.1113/JP271493
Lahteenvuo, J., and Rosenzweig, A. (2012). Effects of aging on angiogenesis. Circ.
Res. 110, 1252–1264. doi: 10.1161/CIRCRESAHA.111.246116
Laranjeira, C., Sandgren, K., Kessaris, N., Richardson, W., Potocnik, A., Vanden
Berghe, P., et al. (2011). Glial cells in the mouse enteric nervous system can
undergo neurogenesis in response to injury. J. Clin. Invest. 121, 3412–3424.
doi: 10.1172/JCI58200
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., and Della-Morte, D. (2018).
Oxidative stress, aging, and diseases. Clin. Interv. Aging 13, 757–772. doi: 10.
2147/CIA.S158513
Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013).
The hallmarks of aging. Cell 153, 1194–1217. doi: 10.1016/j.cell.2013.05.039
Macfarlane, G. T., Gibson, G. R., and Cummings, J. H. (1992). Comparison
of fermentation reactions in different regions of the human colon. J. Appl.
Bacteriol. 72, 57–64. doi: 10.1111/j.1365-2672.1992.tb04882.x
Micheli, L., D’Andrea, G., Ceccarelli, M., Ferri, A., Scardigli, R., and Tirone, F.
(2019). p16Ink4a prevents the activation of aged quiescent dentate gyrus stem
cells by physical exercise. Front. Cell. Neurosci. 13:10. doi: 10.3389/fncel.2019.
00010
Moreno-García, A., Kun, A., Calero, O., Medina, M., and Calero, M. (2018). An
overview of the role of lipofuscin in age-related neurodegeneration. Front.
Neurosci. 12:464. doi: 10.3389/fnins.2018.00464
Nicoletti, C. (2015). Age-associated changes of the intestinal epithelial barrier: local
and systemic implications. Expert Rev. Gastroenterol. Hepatol. 9, 1467–1469.
doi: 10.1586/17474124.2015.1092872
Nilsson, K., and Landberg, G. (2006). Subcellular localization, modification and
protein complex formation of the cdk-inhibitor p16 in Rb-functional and Rb-
inactivated tumor cells. Int. J. Cancer 118, 1120–1125. doi: 10.1002/ijc.21466
O’Mahony, D., O’Leary, P., and Quigley, E. M. (2002). Aging and intestinal
motility: a review of factors that affect intestinal motility in the aged. Drugs
Aging 19, 515–527. doi: 10.2165/00002512-200219070-00005
Phillips, R. J., Kieffer, E. J., and Powley, T. L. (2004). Loss of glia and neurons in the
myenteric plexus of the aged Fischer 344 rat. Anat. Embryol. (Berl) 209, 19–30.
doi: 10.1007/s00429-004-0426-x
Plath, T., Detjen, K., Welzel, M., Von Marshall, Z., Murphy, D., and Schirner, M.
(2000). A novel function for the tumor suppressor p16(INK4a): induction of
anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor. J. Cell. Biol.
150, 1467–1478. doi: 10.1083/jcb.150.6.1467
Proano, M., Camilleri, M., Phillips, S. F., Brown, M. L., and Thomforde, G. M.
(1990). Transit of solids through the human colon: regional quantification in
the unprepared bowel. Am. J. Physiol. 258, 856–862. doi: 10.1152/ajpgi.1990.
258.6.G856
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., and
Ross, O. A. (2018). Age and age-related diseases: role of inflammation triggers
and cytokines. Front. Immunol. 9:586. doi: 10.3389/fimmu.2018.00586
Rheinlander, A., Schraven, B., and Bommhardt, U. (2018). CD45 in human
physiology and clinical medicine. Immunol. Lett. 196, 22–32. doi: 10.1016/j.
imlet.2018.01.009
Richardson, A., Fischer, K. E., Speakman, J. R., de Cabo, R., Mitchell, S. J., Peterson,
C. A., et al. (2016). Measures of healthspan as indices of aging in mice – a
recommendation. J. Gerontol. A Biol. Sci. Med. Sci. 71, 427–430. doi: 10.1093/
gerona/glv080
Saffrey, M. J. (2004). Ageing of the enteric nervous system. Mech. Ageing Dev. 125,
899–906. doi: 10.1016/j.mad.2004.09.003
Sanger, G. J., Broad, J., Kung, V., and Knowles, C. H. (2013). Translational
neuropharmacology: the use of human isolated gastrointestinal tissues. Br. J.
Pharmacol. 168, 28–43. doi: 10.1111/j.1476-5381.2012.02198.x
Sanger, G. J., Holbrook, J. D., and Andrews, P. L. (2011). The translational value of
rodent gastrointestinal functions: a cautionary tale. Trends Pharmacol. Sci. 32,
402–409. doi: 10.1016/j.tips.2011.03.009
Sapieha, P., and Mallette, F. A. (2018). Cellular senescence in postmitotic cells:
beyond growth arrest. Trends Cell. Biol. 28, 595–607. doi: 10.1016/j.tcb.2018.
03.003
Sen, M., Akeno, N., Reece, A., Miller, A. L., Simpson, D. S., and Wikenheiser-
Brokamp, K. A. (2017). p16 controls epithelial cell growth and suppresses
carcinogenesis through mechanisms that do not require Rb1 function.
Oncogenesis 6:e320. doi: 10.1038/oncsis.2017.5
Serrano, M., Hannon, G. J., and Beach, D. (1993). A new regulatory motif in
cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366,
704–707. doi: 10.1038/366704a0
Sherr, C. J. (2006). Divorcing ARF and p53: an unsettled case. Nat. Rev. Cancer 6,
663–673. doi: 10.1038/nrc1954
Souza-Rodrigues, E., Estanyol, J. M., Friedrich-Heineken, E., Olmedo, E., Vera, J.,
et al. (2007). Proteomic analysis of p16INK4a-binding proteins. Proteomics 7,
4102–4111. doi: 10.1002/pmic.200700133
Stein, G. H., Drullinger, L. F., Soulard, A., and Dulic, V. (1999). Differential
roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms
of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19,
2109–2117. doi: 10.1128/MCB.19.3.2109
Straume, O., Sviland, L., and Akslen, L. A. (2000). Loss of nuclear p16 protein
expression correlates with increased tumor cell proliferation (Ki-67) and poor
prognosis in patients with vertical growth phase melanoma. Clin. Cancer Res. 6,
1845–1853.
Tan, F. C., Hutchison, E. R., Eitan, E., and Mattson, M. P. (2014). Are there roles
for brain cell senescence in aging and neurodegenerative disorders? Biogerontol
15, 643–660. doi: 10.1007/s10522-014-9532-9531
Vaiserman, A. M., Koliada, A. K., and Marotta, F. (2017). Gut microbiota: a player
in aging and a target for anti-aging intervention. Ageing Res. Rev. 35, 36–45.
doi: 10.1016/j.arr.2017.01.001
van Deursen, J. M. (2014). The role of senescent cells in ageing. Nature 509,
439–446. doi: 10.1038/nature13193
Wan, C., Liu, J., Nie, X., Zhao, J., Zhou, S., and Duan, Z. (2014). 2, 3,
7, 8-Tetrachlorodibenzo-P-dioxin (TCDD) induces premature senescence in
human and rodent neuronal cells via ROS-dependent mechanisms. PLoS one
9:e89811. doi: 10.1371/journal.pone.0089811
Watters, D. A., Smith, A. N., Eastwood, M. A., Anderson, K. C., Elton, R. A.,
and Mugerwa, J. W. (1985). Mechanical properties of the colon: comparison
of the features of the African and European colon in vitro. Gut 26, 84–92.
doi: 10.1136/gut.26.4.384
Wu, M., Van Nassauw, L., Kroese, A. B., Adriaensen, D., and Timmermans, J. P.
(2003). Myenteric nitrergic neurons along the rat esophagus: evidence for
regional and strain differences in age-related changes. Histochem. Cell Biol. 119,
395–403. doi: 10.1007/s00418-003-0526-3
Zhao, N., Ang, M. K., Yin, X. Y., Patel, M. R., Fritchie, K., and Thorne, L.
(2012). Different cellular p16(INK4a) localisation may signal different survival
outcomes in head and neck cancer. Br. J. Cancer 107, 482–490. doi: 10.1038/bjc.
2012.264
Zhao, P., Hu, Y. C., and Talbot, I. C. (2003). Expressing patterns of p16 and
CDK4 correlated to prognosis in colorectal carcinoma. Wld. J. Gastroenterol.
9, 2202–2206. doi: 10.3748/wjg.v9.i10.2202
Conflict of Interest: GS received funding from Takeda Pharmaceuticals. The
funder was not involved in the study design, collection, analysis, interpretation of
data, the writing of this article, or the decision to submit it for publication. ME
was involved in some parts of the analysis while she was employed by Takeda
Pharmaceuticals, United States.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Palmer, Epton, Crawley, Straface, Gammon, Edgar, Xu, Elahi,
Chin-Aleong, Martin, Bishop, Knowles and Sanger. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Neuroscience | www.frontiersin.org 12 October 2021 | Volume 15 | Article 747067
